Fortress BiotechFBIO -1.62%44 Buyback Yield % is -28.53 as of Jul. 04, 2026. GuruFocus rates FBIO with a GF Score™ of 44/100 and a GF Value™ of $1.24 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 744 Biotechnology companies, Fortress Biotech ranks worse than 75.13% on this metric.
Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.
The historical data trend for Fortress Biotech's Buyback Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FBIO vs RLYB, INO, SEER: Buyback Yield % Comparison
For the Biotechnology subindustry, Fortress Biotech's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fortress Biotech Buyback Yield % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Fortress Biotech's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where Fortress Biotech's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fortress Biotech (FBIO) has a Buyback Yield % of -28.53 as of Jul. 04, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Fortress Biotech and its competitors. According to the industry distribution chart, Fortress Biotech ranks #559 out of 744 companies in the Biotechnology industry, placing it in the top 75.1%.
Is Fortress Biotech's Buyback Yield % too high?
Fortress Biotech's current Buyback Yield % is -28.53. Based on the distribution chart, Fortress Biotech ranks #559 out of 744 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Fortress Biotech has a GF Score™ of 44/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Fortress Biotech's Buyback Yield % compare to RLYB and INO?
According to the Biotechnology industry distribution chart, Fortress Biotech ranks #559 out of 744 companies for Buyback Yield %. This places Fortress Biotech in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Biotechnology company?
A good Buyback Yield % depends on the Biotechnology industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Fortress Biotech and its competitors. Fortress Biotech's current Buyback Yield % is -28.53. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fortress Biotech stock overvalued right now?
Based on GuruFocus' analysis, Fortress Biotech (FBIO) is currently considered Significantly Overvalued. The stock's GF Value™ is $1.24, compared to a current price of $3.03 — trading 144.4% above its estimated fair value. The current Buyback Yield % is -28.53. Fortress Biotech's overall GF Score™ is 44/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Fortress Biotech (FBIO), the current Buyback Yield % is -28.53 as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fortress Biotech (FBIO) Overvalued in 2026?
Based on GuruFocus' analysis, Fortress Biotech stock appears to be overvalued.
The current stock price of $3.03 is trading 144.4% above its estimated GF Value™ of $1.24.
GuruFocus considers Fortress Biotech to be Significantly Overvalued.
Key valuation signals for FBIO:
Buyback Yield %: -28.53
GF Value™: $1.24 vs. price of $3.03 (144.4% above fair value)
No single metric tells the full story. See the FBIO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development.
44GF Score
Get the complete analysis for FBIO
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FBIO has been successfully added to your 
